Revive Therapeutics Ltd. (CVE:RVV) | WebDisclosure

Basculer en Français

10813	Companies
234250	Keywords
163043	Articles
125262	Press releases

Headlines Articles Press releases Revive Therapeutics Ltd.

Home
Companies
Revive Therapeutics Ltd.

BRIEF

published on 07/16/2026 at 00:45, 24 days 15 hours ago

Revive Therapeutics Completes First Tranche of Private Placement

Private Placement Life Sciences Shares And Warrants Funding Initiative Revive Therapeutics
BRIEF

published on 07/16/2026 at 00:45, 24 days 15 hours ago

Revive Therapeutics finalise la première tranche de placements privés

Placement Privé Sciences De La Vie Actions Et Bons De Souscription Initiative De Financement Revive Therapeutics
PRESS RELEASE

published on 07/16/2026 at 00:40, 24 days 15 hours ago

Revive Therapeutics Announces Closing of First Tranche of Non-Brokered Private Placement
Revive Therapeutics Ltd. closes the first tranche of non-brokered private placement, raising $246,920 for infectious diseases and medical countermeasures research and development

Private Placement Research And Development Medical Countermeasures Infectious Diseases Revive Therapeutics Ltd.
BRIEF

published on 06/26/2026 at 22:20, 1 month 12 days ago

Revive Therapeutics Proposes Private Placement to Raise $1 Million

Private Placement Shares Life Sciences Investment Revive Therapeutics
BRIEF

published on 06/26/2026 at 22:20, 1 month 12 days ago

Revive Therapeutics propose un placement privé pour lever 1 million de dollars

Investissement Actions Placement Privé Sciences De La Vie Revive Therapeutics
PRESS RELEASE

published on 06/26/2026 at 22:15, 1 month 12 days ago

Revive Therapeutics Announces Proposed Private Placement
Revive Therapeutics Ltd. announces a private placement offering of up to 31,250,000 units. The gross proceeds may reach approximately $1,000,000 for working capital

Private Placement Working Capital Units Gross Proceeds Revive Therapeutics Ltd.
BRIEF

published on 05/20/2026 at 13:50, 2 months 20 days ago

Revive Therapeutics Expands Bucillamine Program for Broader Applications

Strategic Partnerships Infectious Diseases Defense Applications Patent Expansion Bucillamine
BRIEF

published on 05/20/2026 at 13:50, 2 months 20 days ago

Revive Therapeutics étend son programme Bucillamine à des applications plus larges

Partenariats Stratégiques Maladies Infectieuses Applications De Défense Extension De Brevet Bucillamine
PRESS RELEASE

published on 05/20/2026 at 13:45, 2 months 20 days ago

Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures
Revive Therapeutics Ltd. announces strategic expansion plan for bucillamine, a potential asset for infectious diseases, nerve-agent exposure, pandemics, and medical countermeasures. Company aims to advance preclinical studies and pursue government partnerships

Preclinical Studies Infectious Diseases Government Partnerships Bucillamine Revive Therapeutics
BRIEF

published on 03/11/2026 at 12:35, 4 months 29 days ago

Revive Therapeutics Expands Bucillamine's Patent Portfolio in North America

Patent Portfolio Infectious Diseases Bucillamine Nerve Agent Revive Therapeutics

Accesswire

Published on 08/08/2026 at 00:00, 1 day 16 hours ago

Boron One Announces Change of Auditor
Published on 08/07/2026 at 23:15, 1 day 16 hours ago

Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 1 day 17 hours ago

Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 1 day 17 hours ago

UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 1 day 17 hours ago

Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services

View all ACCESSWIRE

EQS Group

Published on 08/09/2026 at 15:05, 1 hour 2 minutes ago

GearUP and Escape from Tarkov Partner to Enhance Online Gaming Experience for the New Season
Published on 08/09/2026 at 00:01, 16 hours 7 minutes ago

Club Offers for Travel Enthusiasts in Germany
Published on 08/08/2026 at 16:25, 23 hours 42 minutes ago

Bybit Sues North Korea and Lazarus Group, Secures Preliminary Injunction Freezing Stolen Assets in Landmark Crypto Asset Recovery Effort
Published on 08/07/2026 at 23:21, 1 day 16 hours ago

EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 1 day 20 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 08/07/2026 at 18:54, 1 day 21 hours ago

Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 1 day 21 hours ago

Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 1 day 21 hours ago

Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 1 day 21 hours ago

Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 1 day 22 hours ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026

View all LES ECHOS COMFI WIRE